Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

ExpreS2ion Biotech Holding AB (DE:5JD0)

FRANKFURT:5JD0

5JD0

ExpreS2ion Biotech Holding AB

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding DE:5JD0?

Track your performance easily

Link Broker

ExpreS2ion Biotech Holding AB (5JD0) Income Statement

2 Followers

ExpreS2ion Biotech Holding AB Income Statement

Last quarter (Q3 2022), ExpreS2ion Biotech Holding AB's total revenue was kr833.00K, a decrease of -67.31% from the same quarter last year. In Q3, ExpreS2ion Biotech Holding AB's net income was kr-30.70M. See ExpreS2ion Biotech Holding AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	kr 7.51M	kr 12.23M	kr 5.26M	kr 11.69M	kr 8.87M	kr 9.79M
Cost of Revenue	kr 4.92M	kr 7.51M	kr 6.10M	kr 3.40M	kr 2.75M	kr 2.19M
Gross Profit	kr 2.59M	kr 4.72M	kr -843.00K	kr 8.29M	kr 6.12M	kr 7.60M
Operating Expense	kr 93.30M	kr 53.12M	kr 30.35M	kr 25.14M	kr 23.04M	kr 18.53M
Operating Income	kr -90.71M	kr -48.40M	kr -31.20M	kr -16.85M	kr -16.93M	kr -10.93M
Net Non Operating Interest Income Expense	kr 2.47M	kr 209.00K	kr -3.53M	kr -968.00K	kr -597.00K	kr -315.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	kr -88.24M	kr -47.52M	kr -34.92M	kr -19.64M	kr -18.85M	kr -11.75M
Tax Provision	kr -3.85M	kr -3.59M	kr -3.21M	kr -2.38M	kr -2.03M	kr -1.92M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr -84.39M	kr -43.92M	kr -31.71M	kr -17.26M	kr -16.82M	kr -9.84M
Basic EPS	kr -2.28	kr -1.24	kr -1.09	kr -1.17	kr -1.30	-
Diluted EPS	kr -2.36	kr -1.24	kr -1.09	kr -1.17	kr -1.30	-
Basic Average Shares	kr 148.18M	kr 35.36M	kr 29.15M	kr 14.27M	kr 12.97M	-
Diluted Average Shares	kr 148.18M	kr 35.36M	kr 29.15M	kr 14.70M	kr 12.97M	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	kr 98.22M	kr 60.63M	kr 36.45M	kr 28.54M	kr 25.80M	kr 20.72M
Net Income From Continuing And Discontinued Operation	kr -84.39M	kr -43.92M	kr -31.71M	kr -17.26M	kr -16.82M	kr -9.84M
Normalized Income	kr -84.39M	kr -43.92M	kr -31.71M	kr -17.26M	kr -16.82M	kr -9.84M
Interest Expense	kr -248.00K	kr 0.00	kr 3.53M	kr 971.00K	kr 617.00K	kr 461.00K
EBIT	kr -88.49M	kr -47.52M	kr -31.39M	kr -18.67M	kr -18.24M	kr -11.29M
EBITDA	kr -87.22M	kr -45.71M	kr -28.47M	kr -15.79M	kr -15.62M	kr -9.01M

Currency in SEK

ExpreS2ion Biotech Holding AB Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing